Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Telephone Support for Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- NA
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Nurse AMIE: Addressing Metastatic Individuals Everyday
- Status
- COMPLETED
- Phase
- NA
Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases
- Status
- TERMINATED
- Phase
- NA
A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body
- Status
- COMPLETED
- Phase
- PHASE1
ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC
- Status
- UNKNOWN
- Phase
- PHASE2
Pain Phenotyping of Patients With Bone Cancer Pain
- Status
- UNKNOWN
- Phase
- N/A
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
- Status
- COMPLETED
- Phase
- N/A
ModraDoc006/r in Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of ODM-209
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3